orlistat · ORLISTAT 60 mg/1 · Capsule · Oral · Haleon US Holdings LLC
NDC 00135-0461-01 · 60 CAPSULE in 1 BOTTLE · NDA · View full market →
5 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.4536 per unit over the past year.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aphena Pharma Solutions - Tennessee, LLC | ORLISTAT 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Pharma Solutions, LLC | ORLISTAT 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Delpharm Milano Srl | ORLISTAT 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Haleon US Holdings LLC | ORLISTAT 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| H2-Pharma LLC | ORLISTAT 120 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Alli — NDC 00135-0461-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00135046101.
Free to cite with attribution — see how the data is put together.